Latest news
Definium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss - simplywall.stsimplywall.st · Sat, 08 Aug 2026 23:35:37 GMTDefinium Therapeutics, Inc. (NASDAQ:DFTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:43:13 GMTDefinium Therapeutics (NASDAQ:DFTX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTDefinium Therapeutics (DFTX) Reports Strong Phase III Data, Is It Still Below Fair Value? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 21:28:36 GMTDefinium Therapeutics (DFTX) Boosts Cash Reserves Amid Psychedelic Medicine Advances - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:29:32 GMTIs Definium Therapeutics Inc (DFTX) Facing Challenges After Repo - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:04:00 GMTDefinium Therapeutics Inc (DFTX) (Q2 2026) Earnings Call Highlights: Record Phase III MDD ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:10:44 GMTDFTX Stock Clocks Best Day In Over Two Years On 'Best-Case' Clinical Results For Oral Lysergide In Depression - StocktwitsStocktwits · Fri, 07 Aug 2026 01:29:54 GMT